BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14676831)

  • 1. Inhibition of prostate tumor growth by overexpression of NudC, a microtubule motor-associated protein.
    Lin SH; Nishino M; Luo W; Aumais JP; Galfione M; Kuang J; Yu-Lee LY
    Oncogene; 2004 Apr; 23(14):2499-506. PubMed ID: 14676831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for the WWOX gene in prostate cancer.
    Qin HR; Iliopoulos D; Semba S; Fabbri M; Druck T; Volinia S; Croce CM; Morrison CD; Klein RD; Huebner K
    Cancer Res; 2006 Jul; 66(13):6477-81. PubMed ID: 16818616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for NudC, a dynein-associated nuclear movement protein, in mitosis and cytokinesis.
    Aumais JP; Williams SN; Luo W; Nishino M; Caldwell KA; Caldwell GA; Lin SH; Yu-Lee LY
    J Cell Sci; 2003 May; 116(Pt 10):1991-2003. PubMed ID: 12679384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
    Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
    Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells.
    Pennati M; Binda M; Colella G; Zoppe' M; Folini M; Vignati S; Valentini A; Citti L; De Cesare M; Pratesi G; Giacca M; Daidone MG; Zaffaroni N
    Oncogene; 2004 Jan; 23(2):386-94. PubMed ID: 14724567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
    Chiu FL; Lin JK
    Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and analysis of human UroplakinII promoter and its application for gene therapy in bladder cancer.
    Zhu HJ; Zhang ZQ; Zeng XF; Wei SS; Zhang ZW; Guo YL
    Cancer Gene Ther; 2004 Apr; 11(4):263-72. PubMed ID: 14963492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
    Suy S; Mitchell JB; Samuni A; Mueller S; Kasid U
    Cancer; 2005 Mar; 103(6):1302-13. PubMed ID: 15685617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability.
    Fraser MM; Watson PM; Fraig MM; Kelley JR; Nelson PS; Boylan AM; Cole DJ; Watson DK
    Cancer Res; 2005 Jul; 65(14):6228-36. PubMed ID: 16024624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-suppression function of transcription factor USF2 in prostate carcinogenesis.
    Chen N; Szentirmay MN; Pawar SA; Sirito M; Wang J; Wang Z; Zhai Q; Yang HX; Peehl DM; Ware JL; Sawadogo M
    Oncogene; 2006 Jan; 25(4):579-87. PubMed ID: 16186802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation-associated -7 (mda-7)/interleukin-24 (IL-24) gene.
    Saito Y; Miyahara R; Gopalan B; Litvak A; Inoue S; Shanker M; Branch CD; Mhashilkar AM; Roth JA; Chada S; Ramesh R
    Cancer Gene Ther; 2005 Mar; 12(3):238-47. PubMed ID: 15578066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
    Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway.
    Ni J; Wen X; Yao J; Chang HC; Yin Y; Zhang M; Xie S; Chen M; Simons B; Chang P; di Sant'Agnese A; Messing EM; Yeh S
    Cancer Res; 2005 Nov; 65(21):9807-16. PubMed ID: 16267002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R).
    Ling MT; Wang X; Lee DT; Tam PC; Tsao SW; Wong YC
    Carcinogenesis; 2004 Apr; 25(4):517-25. PubMed ID: 14688027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated delivery of human IFNgamma gene inhibits prostate cancer growth.
    Zhao P; Zhu YH; Wu JX; Liu RY; Zhu XY; Xiao X; Li HL; Huang BJ; Xie FJ; Chen JM; Ke ML; Huang W
    Life Sci; 2007 Aug; 81(9):695-701. PubMed ID: 17714738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor growth in xenografted nude mice with adenovirus-mediated endostatin gene comparison with recombinant endostatin protein.
    Liang ZH; Wu PH; Li L; Xue G; Zeng YX; Huang WL
    Chin Med J (Engl); 2004 Dec; 117(12):1809-14. PubMed ID: 15603709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
    Zhang M; Mukherjee N; Bermudez RS; Latham DE; Delaney MA; Zietman AL; Shipley WU; Chakravarti A
    Prostate; 2005 Aug; 64(3):293-302. PubMed ID: 15754318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined ionizing radiation and sKDR gene delivery for treatment of prostate carcinomas.
    Kaliberov SA; Kaliberova LN; Buchsbaum DJ
    Gene Ther; 2005 Mar; 12(5):407-17. PubMed ID: 15616600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-suppressive activity of CD66a in prostate cancer.
    Luo W; Tapolsky M; Earley K; Wood CG; Wilson DR; Logothetis CJ; Lin SH
    Cancer Gene Ther; 1999; 6(4):313-21. PubMed ID: 10419049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.